Circassia Plans $285 Million London IPO for Allergy Vaccines

... prescription antihistamines to combat allergies was estimated at $6.8 billion in 2012 by IMS Health Holdings Inc., a Danbury, Connecticut-based health-care information-technology company. "This listing creates an excellent opportunity to build a ...



via Danbury Newswire http://ift.tt/1kgeese